As previously announced, Calmark filed two more patent applications to the Swedish Intellectual Property Office (PRV) on July 10, 2018. One patent relates to the unique technical solution for the single-use item, which ensures that exact blood volume and measurement time are achieved independently of the user. The second is a method patent concerning the reading of the biomarker bilirubin using a colorimetric analysis method.
These patents have now been granted by PRV and provide protection on the Swedish market until July 2038. The patents have been developed in close cooperation with the company’s patent agent Hynell Patenttjänst AB.
Patent protection in more markets will now be filed.
Including the new patents, Calmark owns fifteen patents and five design protections for the reader and the single-use item.
"Today's announcement is gratifying," says Anna Söderlund, CEO of Calmark. “For Calmark, it is strategically important to have broad patent protection for the company's technologies and methods. We are continuously trying to patent our innovations. Good IP protection will strengthen us in the global market launch.”
Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation.